324 related articles for article (PubMed ID: 26299750)
21. Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice.
Datta D; Bansal GP; Kumar R; Ellefsen B; Hannaman D; Kumar N
Clin Vaccine Immunol; 2015 Sep; 22(9):1013-9. PubMed ID: 26135972
[TBL] [Abstract][Full Text] [Related]
22. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
Barr PJ; Green KM; Gibson HL; Bathurst IC; Quakyi IA; Kaslow DC
J Exp Med; 1991 Nov; 174(5):1203-8. PubMed ID: 1940798
[TBL] [Abstract][Full Text] [Related]
23. Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
Talaat KR; Ellis RD; Hurd J; Hentrich A; Gabriel E; Hynes NA; Rausch KM; Zhu D; Muratova O; Herrera R; Anderson C; Jones D; Aebig J; Brockley S; MacDonald NJ; Wang X; Fay MP; Healy SA; Durbin AP; Narum DL; Wu Y; Duffy PE
PLoS One; 2016; 11(10):e0163144. PubMed ID: 27749907
[TBL] [Abstract][Full Text] [Related]
24. Poor CD4
Zaric M; Marini A; Nielsen CM; Gupta G; Mekhaiel D; Pham TP; Elias SC; Taylor IJ; de Graaf H; Payne RO; Li Y; Silk SE; Williams C; Hill AVS; Long CA; Miura K; Biswas S
Front Immunol; 2021; 12():732667. PubMed ID: 34659219
[No Abstract] [Full Text] [Related]
25. Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.
Gozar MM; Muratova O; Keister DB; Kensil CR; Price VL; Kaslow DC
Exp Parasitol; 2001 Feb; 97(2):61-9. PubMed ID: 11281702
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
Kou X; Zheng W; Du F; Liu F; Wang M; Fan Q; Cui L; Luo E; Cao Y
Parasit Vectors; 2016 Apr; 9():190. PubMed ID: 27038925
[TBL] [Abstract][Full Text] [Related]
27. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
Coban C; Philipp MT; Purcell JE; Keister DB; Okulate M; Martin DS; Kumar N
Infect Immun; 2004 Jan; 72(1):253-9. PubMed ID: 14688103
[TBL] [Abstract][Full Text] [Related]
28. A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
Chowdhury DR; Angov E; Kariuki T; Kumar N
PLoS One; 2009 Jul; 4(7):e6352. PubMed ID: 19623257
[TBL] [Abstract][Full Text] [Related]
29. Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
de Graaf H; Payne RO; Taylor I; Miura K; Long CA; Elias SC; Zaric M; Minassian AM; Silk SE; Li L; Poulton ID; Baker M; Draper SJ; Gbesemete D; Brendish NJ; Martins F; Marini A; Mekhaiel D; Edwards NJ; Roberts R; Vekemans J; Moyle S; Faust SN; Berrie E; Lawrie AM; Hill F; Hill AVS; Biswas S
Front Immunol; 2021; 12():694759. PubMed ID: 34335606
[TBL] [Abstract][Full Text] [Related]
30. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
Mlambo G; Maciel J; Kumar N
Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
[TBL] [Abstract][Full Text] [Related]
31. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
McGuire KA; Miura K; Wiethoff CM; Williamson KC
Malar J; 2017 Jun; 16(1):254. PubMed ID: 28619071
[TBL] [Abstract][Full Text] [Related]
32. Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.
Kumar R; Nyakundi R; Kariuki T; Ozwara H; Nyamongo O; Mlambo G; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2013 Jun; 31(31):3140-7. PubMed ID: 23684840
[TBL] [Abstract][Full Text] [Related]
33. Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.
Coban C; Ishii KJ; Stowers AW; Keister DB; Klinman DM; Kumar N
Infect Immun; 2004 Jan; 72(1):584-8. PubMed ID: 14688140
[TBL] [Abstract][Full Text] [Related]
34. Heterologous Expression and Evaluation of Novel
de Jong RM; Singh SK; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Stone WJR; Locke E; Plieskatt J; Theisen M; Bousema T; Jore MM
Front Immunol; 2022; 13():909060. PubMed ID: 35812379
[TBL] [Abstract][Full Text] [Related]
35. Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
Parzych EM; Miura K; Long CA; Burns JM
PLoS One; 2020; 15(4):e0232355. PubMed ID: 32348377
[TBL] [Abstract][Full Text] [Related]
36. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
MacDonald NJ; Nguyen V; Shimp R; Reiter K; Herrera R; Burkhardt M; Muratova O; Kumar K; Aebig J; Rausch K; Lambert L; Dawson N; Sattabongkot J; Ambroggio X; Duffy PE; Wu Y; Narum DL
J Biol Chem; 2016 Sep; 291(38):19913-22. PubMed ID: 27432885
[TBL] [Abstract][Full Text] [Related]
37. Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.
Sala KA; Angrisano F; Da DF; Taylor IJ; Churcher TS; Blagborough AM
Sci Rep; 2018 Jan; 8(1):1573. PubMed ID: 29371619
[TBL] [Abstract][Full Text] [Related]
38. Strategies & recent development of transmission-blocking vaccines against
Chaturvedi N; Bharti PK; Tiwari A; Singh N
Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
[TBL] [Abstract][Full Text] [Related]
39. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
Healy SA; Anderson C; Swihart BJ; Mwakingwe A; Gabriel EE; Decederfelt H; Hobbs CV; Rausch KM; Zhu D; Muratova O; Herrera R; Scaria PV; MacDonald NJ; Lambert LE; Zaidi I; Coelho CH; Renn JP; Wu Y; Narum DL; Duffy PE
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561016
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
Farrance CE; Chichester JA; Musiychuk K; Shamloul M; Rhee A; Manceva SD; Jones RM; Mamedov T; Sharma S; Mett V; Streatfield SJ; Roeffen W; van de Vegte-Bolmer M; Sauerwein RW; Wu Y; Muratova O; Miller L; Duffy P; Sinden R; Yusibov V
Hum Vaccin; 2011; 7 Suppl():191-8. PubMed ID: 21266847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
